It has been estimated that field loss may take 10 to 15 years to occur after the onset of raised pressure.6 There is therefore a protracted period of time during which optic nerve fibre damage, currently undetectable in vivo, is occurring. Indeed, recent evidence from enucleated eyes has shown that there is optic nerve fibre loss in ocular hypertension in the absence of manifest field loss.7 Clearly, more sensitive
An initial phase in chronic simple glaucoma may be identified when there is ocular hypertension (raised intraocular pressure (IOP) greater than 21 mmHg) but no observable pathological cupping of the optic disc and no glaucomatous field defect. Many ocular hypertensive patients never develop glaucoma, but others are in the early stages of the disorder.' If the latter patients are not treated, they will develop glaucomatous cupping of the optic disc and visual field defects. The number of patients who develop glaucoma from ocular hypertension has been estimated variously as 0.4%,2 0O5%,' 3H2%,3 and 17-4%. 4 When the IOP is persistently above 31 mmHg the proportion of patients developing glaucoma is thought to be considerably higher, about 40%.1 Thus patients with ocular hypertension, to a greater or lesser extent, appear to be more at risk of developing glaucoma than an age matched population with normal pressures. It has been estimated that field loss may take 10 to 15 years to occur after the onset of raised pressure. 6 There is therefore a protracted period of time during which optic nerve fibre damage, currently undetectable in vivo, is occurring. Indeed, recent evidence from enucleated eyes has shown that there is optic nerve fibre loss in ocular hypertension in the absence of manifest field loss.7 Clearly, more sensitive Correspondence to Dr J E Ross. *Current address: Visual Sciences Department, Aston University, Gosta Green, Birmingham BE4 7ET methods for differentiating between glaucomatous and non-glaucomatous ocular hypertensive patients are needed to provide specific criteria for diagnosis and therapy.
Many researchers have shown that spatial contrast sensitivity in glaucoma patients can be quite severely depressed;"' and that the reduction in sensitivity can be correlated with other measures of the progression and extent of the disease, such as field loss." These losses of contrast sensitivity have been found even in patients with early glaucoma who show no central visual field abnormalities-that is, in the central 150. There is also some evidence to suggest that both contrast sensitivity' 12 and colour vision may be impaired in patients with ocular hypertension.'ll'5 Therefore it seemed a logical step to determine whether spatial contrast sensitivity is depressed in some ocular hypertensive patients but not in others. We used an accurate and reliable technique to measure contrast sensitivity'6 in order to determine its usefulness as an early test of nerve fibre loss in ocular hypertension.
Materials and methods

SUBJECTS
Patients with ocular hypertension were recruited as they presented to the Results Monocular visual acuity in both patient groups ranged from 6/4 to 6/12 (mean 6/7.5). IOP readings are presented in Table 2 . The grand mean pressure is the mean of all recorded pressures since the patient first attended the Eye Hospital. It can be seen from Table 2 that the only IOP measure which differed between the two groups was the group mean IOP at last visit. This result is attributable to the fact that one group was on pressure lowering therapy and the other was not.
A qualitative assessment of the cup to disc ratio was made. In 48 ocular hypertensive eyes this ratio was less than or equal to 0O5. Two of the remaining eyes had a ratio of 0-8 (same patient), and one eye had a ratio of 0*6, and thus one might have considered these eyes to be abnormal. However, in each case the discs were a good colour and the cups were i 1200 circular, with a healthy rim of tissue at the disc margin. They were therefore considered to be colobomatous discs. Cup to disc ratios exceeded 0-5 in some eyes, which did not fulfil the eligibility criteria for ocular hypertension; details of the findings for these eyes are given in Table 4b .
The criterion for abnormal contrast sensitivity responses is based on our previous measurements of subjects (n=70), stratified by age, with normal vision. 6 Our technique of measurement was found to be reliable, with a correlation coefficient of 0.88 or better on a test/retest basis for each spatial frequency. In the present study a response was recorded as abnormal when one or more of the responses to the three spatial frequencies between one and six cycles per degree of visual angle (cpd) were more than two standard deviations (SD) from the age matched mean normal value. By this criterion 20 of the 28 eyes in group 1 and 12 of the 23 eyes in group 2 had abnormal The results for these patients are presented in Table 3b . All but two of the above nine patients produced asymmetrical results. These two patients were also receiving treatment to both eyes. The first patient was on epinephrine 1% b.d. and had abnormal contrast sensitivity in the study eye but had symmetrical optic discs. The grand mean TOPs were 21 mmHg in both eyes. In the fellow eye a 2°nasal step was found on Topcon perimetry, as mentioned above, but normal contrast sensitivity. The second patient was on timolol 0.25% b.d. and had normal contrast sensitivity in the ocular hypertensive eye, but abnormal sensitivity in the fellow eye. The grand mean IOPs were 22 mmHg in both eyes, and the optic disc in the fellow eye had a cup to disc ratio of 0-6, with narrowing of the superior rim. If the eyes with suspicious discs and possible visual field defects are excluded, there remain four eyes which are normotensive. In each of them contrast sensitivity in the study and fellow eye was similar, with abnormal responses bilaterally in three patients and normal responses bilaterally in one patient. Thus IOP differences between the eyes were not reflected in this result.
Asymmetry between optic discs is usually con- Tables 4a and 4b . Interestingly, all but one patient produced symmetrical contrast sensitivity results. However, this paradoxical result may reflect the small cup to disc ratio differences between the two eyes or the qualitative aspect of the assessment rather than a genuine lack of correlation between optic disc appearance and contrast sensitivity. An Octopus perimeter enabled us to perform automated field measurements on 13 eyes in 11 patients. However, even when this more rigorous procedure was used, the visual fields in 10 eyes were normal; the other three eyes showed early glaucomatous field defects. These defects were relative arcuate scotomata, in each case adjoining the blind spot. In two of the three eyes Octopus field testing revealed increased thresholds in the foveal area. In these three eyes contrast sensitivity was abnormal (Table 5 ). The three patients with Octopus field defects were in group 1 (no treatment). In two of the cases the IOPs (both the grand mean and the IOP recorded on the day of the test) were only marginally raised, the highest reading being 23 5 mmHg. The third patient was found to have pressures of 36 and 28 mmHg in the right and left eyes respectively and he was placed on timolol drops 05% b.d. to both eyes.
It might be argued that the reason for the high proportion of patients with abnormal contrast sensitivity was poor selection, and that if a more rigorous visual field criterion had been used some patients would have been diagnosed as having chronic simple glaucoma. The above mentioned results from an Octopus automated perimeter on a sample of the eyes included in the study show that this is unlikely to have been the case.
The relationship between contrast sensitivity and the grand mean IOP was examined. In the untreated group there was no significant difference between the mean TOPs of the 20 eyes with reduced sensitivity and the eight which produced normal responses (t=O-199, df=26, p>0-05 responses, and 11 were within normal limits. Again, differences in grand mean IOPs for the two responses were not statistically significant (t=1-8757, df=21, p>O0OS).
Discussion
In this study 63% (32 eyes) of the ocular hypertensive eyes showed an impairment of central spatial contrast sensitivity. Individual loss of contrast sensitivity was not related to the grand mean IOPs, and a number of patients with unilateral ocular hypertension who had consistently normotensive fellow eyes nevertheless showed impaired contrast sensitivity in both eyes. It is accepted that some patients with ocular hypertension will develop chronic simple glaucoma. Those patients with higher pressures (for example, greater than 30 mmHg) do appear to be at greater risk of developing manifest chronic simple glaucoma,5 but when all levels of raised IOP are considered the number of ocular hypertensive patients developing chronic simple glaucoma is surprisingly low.' However, until criteria exist for determining which patients are likely to suffer visual damage, all patients with raised IOP have to be considered at risk.
More than half of our ocular hypertensive patients had defective contrast sensitivity. 71% of eyes in group 1 and 52% in group 2 performed at a level which was more than 2 SDs from the age matched norm for one or more spatial frequencies. These abnormal results were obtained from eyes with good visual acuity and full Topcon fields. Surprisingly, of the 11 patients who had Octopus field tests (a more rigorous method of field testing) only three were found to have changes which might be indicative of glaucoma. Both the contrast sensitivity test and the
Octopus field test sample the central 10-15°of vision, but it appears that contrast sensitivity is the more sensitive measure of function for central retina.
It is apparent from our results that a far greater proportion of our patients showed reduced contrast sensitivity (and, presumably, optic nerve damage) than might have been expected on the basis of previous reports. 8 12 One reason for this discrepancy might be that our control population, used for aged matched comparisons, was not representative. In the present study the comparisons are based on a control population of 70 subjects (31 male and 39 female) stratified by age. 16 Moreover, these control data have been supplemented by data from a further 100 normal subjects whose contrast sensitivities fall well within the limits defined by the earlier population. It seems likely, therefore, that in the standardised conditions of the present study a depression of sensitivity greater than 2 SDs below the mean is likely to represent abnormality.
An alternative explanation is that some aspect of the selection of our ocular hypertensive group, either the inclusion/exclusion criteria or the way in which patients were referred, meant that our patients were more at risk of developing optic nerve damage than another group of ocular hypertensive patients not selected in the same manner. This is a possibility, though we have been unable to determine what aspect of the selection/referral procedure could account for our results.
Early glauconiTatous defects are typically thought to occur outside the central 5-10°of the visual field.23 However, there is increasing evidence suggesting that vision in central retina is abnormal in ocular hypertension and early glaucoma. Colour vision defects which involve central vision have been reported in ocular hypertension by Lakowski et al. 13 and in glaucoma and ocular hypertension by Fishman et al. ' in the total number of nerve fibres below the mean control number varied from 12% to 40% in these patients.
In the presence of glaucoma one might expect the eye with the more advanced cupping or visual field defect to have a greater loss of contrast sensitivity. Such an association has been reported by Atkin et al.'2 and Ross" in glaucoma patients. One might also expect there to be a relationship between IOP and contrast sensitivity loss. In our ocular hypertensive patients no association of this kind was found. All but three patients with bilateral ocular hypertension (85%) produced symmetrical contrast sensitivity results (that is, both eyes were either normal or abnormal) despite the fact that in most cases there were pressure differences between the patients' right and left eyes. It is also surprising that seven of the nine patients in whom only one eye satisfied the criteria for ocular hypertension produced symmetrical results, since four of these seven had normotensive fellow eyes and three of these four produced abnormal results. From the point of view of screening, infrequent IOP measurements alone may be a poor indicator of the existence of optic nerve fibre damage. When considering the cause of optic nerve fibre damage in normotensive fellow eyes the inference may be that periods of raised pressure in the fellow eyes have been missed.
From these findings it is clear that contrast sensitivity detects visual loss earlier than rigorous field testing. It is therefore unwise to assume that optic nerve fibres in ocular hypertensive eyes are undamaged if the visual field appears to be full. Our results suggest that the value of ocular pressure measurement for predicting early optic nerve damage is limited, though its use as part of a battery of clinical tests is still important.
Traditionally clinicians do not put a patient on to treatment on the basis of raised IOP alone, unless the pressure is very high (for example, >30 mmHg). Usually more emphasis is placed on optic disc appearance and perimetry. In this study we found that there was no obvious relationship between the level of TOP over a wide range and contrast sensitivity loss in either group. This result was hardly surprising in the case of group 2, because, if therapy is effective, the IOP of all of the treated patients should be within normal limits irrespective of the progression of the disease. However, the finding that there is no significant difference in mean IOP between untreated patients who appear to have viStual loss and those who do not is very interesting, and Shows that IOP measurement, over a wide range, is a very poor indicator of optic nerve fibre damage. It confitms that the policy of not treating patients on the basis of IOP alone is prudent. However, our contrast sensitivity results on patients with normal discs and fields show that, if treatment is delayed until manifest signs can be observed (that is, disc changes and/or field defect), extensive visual loss may already have taken place. This is reinforced by recent histopathological studies. 7 In this study we investigated a group of patients with raised ocular pressure but with no observable optic disc changes and no field loss. This appears to be a uniform group and, with the exception of patients with very high pressures, the clinician has no specific criterion for treating some patients and not treating others. Our test divides these patients into two groups, those with normal contrast sensitivity and those with abnormal contrast sensitivity. We believe that reduced contrast sensitivity reflects early optic nerve damage and that contrast sensitivity measurements might therefore be used as a criterion for therapy in ocular hypertension.
It has not yet been demonstrated directly that contrast sensitivity is a valid measure of optic nerve damage. However, this could be done simply by a longitudinal study of ocular hypertensive patients. At the same time it would also be interesting to see whether treatment of these patients with pressure reducing therapy is effective in halting and possibly reversing any optic nerve damage that may be occurring, shown by contrast sensitivity loss.
Until such a study has been carried out, we feel it is very important that patients who are referred with raised IOP should undergo rigorous tests of central vision, such as contrast sensitivity and colour vision, in addition to routine visual field testing. 
